01 1SM Biomed SDN.BHD.
01 1Hiple Co., Ltd.
01 1Erythromycin
01 1Malaysia
Registrant Name : Hiple Co., Ltd.
Registration Date : 2015-11-17
Registration Number : 20120601-107-F-64-02(1)
Manufacturer Name : SM Biomed SDN.BHD.
Manufacturer Address : Lot 90, Sungai Petani Industrial Estate, 08000 Sungai Petani, Kedah, Malaysia (Erythr...
84
PharmaCompass offers a list of Erythromycin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Erythromycin manufacturer or Erythromycin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Erythromycin manufacturer or Erythromycin supplier.
A Ery-Sol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ery-Sol, including repackagers and relabelers. The FDA regulates Ery-Sol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ery-Sol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ery-Sol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Ery-Sol supplier is an individual or a company that provides Ery-Sol active pharmaceutical ingredient (API) or Ery-Sol finished formulations upon request. The Ery-Sol suppliers may include Ery-Sol API manufacturers, exporters, distributors and traders.
click here to find a list of Ery-Sol suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ery-Sol Drug Master File in Korea (Ery-Sol KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ery-Sol. The MFDS reviews the Ery-Sol KDMF as part of the drug registration process and uses the information provided in the Ery-Sol KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ery-Sol KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ery-Sol API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ery-Sol suppliers with KDMF on PharmaCompass.
